drugset / Trial / NCT01060228

A Drug Interaction Study of Valproic Acid and Single-dose Paliperidone Extended-Release (ER) in Healthy Men

NCT01060228

NaSingle-groupOpen-label

Summary

The purpose of this study is to evaluate the effect of valproic acid (VPA) on the pharmacokinetics (blood levels) of a single oral dose of an extended-release formulation of paliperidone in healthy male volunteers.

Timeline

Start
2009-01
Primary completion
Completion
2009-02

Drugs

EvaluationDrugModalityDoseRoute
Subject Divalproex Sodium Small molecule 1000 mg Oral
Subject Paliperidone Unknown 12 mg Oral

Indications